Rarecells, Inc. Announces Breakthrough Publication on Circulating Giant Cancer Cells Detected in Patients with MDS

Rarecells, Inc. has made an exciting announcement about a major breakthrough in the detection of Circulating Giant Cancer Cells (CGCCs) in patients with Myelodysplastic Syndrome (MDS). &nbsp In collaboration with Dr. Azra Raza from Columbia University Irving Medical Center, Rarecells has conducted groundbreaking research that has revealed the presence of CGCCs in MDS patients for the first time ..